Litcius/Paper detail

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer’s disease

Dipanjan Karati, Shreyasi Meur, Souvik Roy, Swarupananda Mukherjee, Biplab Debnath, Sajal Kumar Jha, Biresh Kumar Sarkar, S. Naskar, Priya Ghosh

2024Naunyn-Schmiedeberg s Archives of Pharmacology28 citationsDOI

Topics & Concepts

GSK-3Glycogen synthaseGSK3BDiseaseAlzheimer's diseaseNeuroscienceGlycogenKinaseBiologyChemistryBiochemistryMedicineInternal medicineWnt/β-catenin signaling in development and cancerNuclear Receptors and SignalingGenetics and Neurodevelopmental Disorders
Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer’s disease | Litcius